NCT02025010 2025-04-15
Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
7 trialsNCT06227156 2024-05-23
Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer
RemeGen Co., Ltd.
Phase 2 Recruiting
NCT02346578 2021-09-16
Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.
Osaka City University
Phase 2 Completed
NCT03261336 2021-02-08
Oral Calcitriol With Ketoconazole in CRPC
Inova Health Care Services
Phase 2 Terminated
NCT03506997 2020-07-22
PERSEUS1
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT03696186 2018-10-09
STAMP
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT01487902 2011-12-08
The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer
Asan Medical Center
Phase 2 Unknown